GlassScriptPhysician profile
Alyssa Miller
NPI 1093186884
$1,673.03
in general payments reported to CMS, 2019-2025
20 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.92 · 2022: $79.20 · 2023: $774 · 2024: $506 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $228.71 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $222.22 | 2023-2024 | Cologuard Collection Kit |
| Abbvie INC. | $182.73 | 2022-2024 | |
| Amgen INC. | $145.37 | 2022-2024 | Repatha, Otezla, Prolia |
| Pfizer INC. | $141.36 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.80 | 2023-2024 | Xifaxan, Trulance |
| Novo Nordisk INC | $76.63 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $73.15 | 2023-2024 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $72.58 | 2023-2024 | Farxiga, Fasenra, Breztri |
| Boston Scientific Corporation | $72.52 | 2024-2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $56.31 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.83 | 2023-2024 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $47.19 | 2021-2024 | Rexulti |
| Sanofi Pasteur INC. | $46.54 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $45.06 | 2023-2024 | Livalo, Seglentis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $38.49 | 2023 | Xarelto |
| Astellas Pharma US INC | $31.37 | 2023 | Veozah |
| Amarin Pharma, INC. | $29.19 | 2021 | |
| Lilly USA, LLC | $16.86 | 2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $14.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.